Mobile

A Study to Research what the body does with the study drug after treatment with Simeprevir, Sofosbuvir and Ledipasvir in patients with Chronic Hepatitis C Virus Genotype 1 Infection who have not yet s...

Mise à jour : Il y a 4 ans
Référence : EUCTR2015-000459-25

A Study to Research what the body does with the study drug after treatment with Simeprevir, Sofosbuvir and Ledipasvir in patients with Chronic Hepatitis C Virus Genotype 1 Infection who have not yet started anti-viral treatment

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

- To evaluate the effect of multiple-dose LDV 90 mg qd given in combination with SOF 400 mg qd on the steady-state PK of SMV 150 mg qd in chronic HCV genotype 1 infected subjects. - To evaluate the effect of multiple-dose SMV 150 mg qd on the steady-state PK of LDV 90 mg qd given in combination with SOF 400 mg qd in chronic HCV genotype 1 infected subjects.

Critère d'inclusion

  • Chronic Hepatitus C Virus (HCV) Genotype 1 Infection

Liens